NEWSROOM

San Jose, Costa Rica, January 2025-. SteinCares, a leading specialty healthcare company in Latin America, has announced a commercialization agreement with Molteni Farmaceutici, an Italian company specializing in pain management, to expand access to Oramorph®, a Molteni Farmaceutici proprierty pharma product novel morphine oral solution across the region. The companies will

GUANGZHOU, China and San Jose, Costa Rica – SteinCares, a leading specialty healthcare company in Latin America, and Bio-Thera Solutions, a commercial-stage biopharmaceutical company developing innovative therapies and biosimilars, today announced an expansion of their partnership with the addition of a third biosimilar. Under the agreement, SteinCares will have exclusive rights

San Jose, Costa Rica, October 29, 2024 – SteinCares, a leading specialty healthcare company in Latin America, announces a new distribution agreement with Biotest AG, a multinational company specializing in biological therapies derived from human plasma, for the commercialization and distribution of Haemoctin® throughout selected Latin American countries (Chile, Colombia, Costa Rica,

San Jose, Costa Rica, August 2024-. SteinCares, a leading specialty healthcare company in Latin America, announces the acquisition of Laboratorios C&D Pharma in Chile. This strategic transaction consolidates the company’s position in the market and expands its portfolio of pain management and palliative care treatments. The agreement will drive SteinCares’ growth

San Jose, Costa Rica, August 2024 – SteinCares, a leading specialty healthcare company in Latin America, has expanded its exclusive licensing agreement with Pharmacosmos for Monofer® in Colombia. This innovative therapy addresses iron deficiency anemia, a condition that affects 25% of children under the age of 5 and half of pregnant

Guangzhou, China and San José, Costa Rica – Bio-Thera Solutions, a commercial-stage biopharmaceutical company developing innovative therapies and biosimilars, and SteinCares, one of Latin America’s leading specialty healthcare companies, announced today a new licensing agreement for two biosimilars under which SteinCares will have exclusive rights to distribute and market Bio-Thera’s pharmaceuticals